NYSE:CNMDMedical Equipment
Why CONMED (CNMD) Is Down 5.3% After Raising 2026 Outlook And Exiting Gastroenterology Portfolio
In late April 2026, CONMED Corporation reported first-quarter results with sales of US$317.05 million and higher earnings, raised its full-year 2026 revenue outlook to US$1.35–US$1.38 billion, and confirmed it had completed the divestiture of its remaining gastroenterology portfolio.
Management’s decision to exit lower-margin gastroenterology products while simultaneously upgrading guidance and signaling interest in disciplined acquisitions highlights a sharpening focus on higher-margin...